BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33356003)

  • 1. Patient-derived scaffolds as a model of colorectal cancer.
    Parkinson GT; Salerno S; Ranji P; Håkansson J; Bogestål Y; Wettergren Y; Ståhlberg A; Bexe Lindskog E; Landberg G
    Cancer Med; 2021 Feb; 10(3):867-882. PubMed ID: 33356003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-fluorouracil treatment of patient-derived scaffolds from colorectal cancer reveal clinically critical information.
    Salerno S; Ståhlberg A; Holdfeldt A; Bexe Lindskog E; Landberg G
    J Transl Med; 2022 May; 20(1):209. PubMed ID: 35562738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decellularized colorectal cancer matrix as bioactive microenvironment for in vitro 3D cancer research.
    Piccoli M; D'Angelo E; Crotti S; Sensi F; Urbani L; Maghin E; Burns A; De Coppi P; Fassan M; Rugge M; Rizzolio F; Giordano A; Pilati P; Mammano E; Pucciarelli S; Agostini M
    J Cell Physiol; 2018 Aug; 233(8):5937-5948. PubMed ID: 29244195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
    Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
    Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mimicking Metastases Including Tumor Stroma: A New Technique to Generate a Three-Dimensional Colorectal Cancer Model Based on a Biological Decellularized Intestinal Scaffold.
    Nietzer S; Baur F; Sieber S; Hansmann J; Schwarz T; Stoffer C; Häfner H; Gasser M; Waaga-Gasser AM; Walles H; Dandekar G
    Tissue Eng Part C Methods; 2016 Jul; 22(7):621-35. PubMed ID: 27137941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer Stemness, Immune Cells, and Epithelial-Mesenchymal Transition Cooperatively Predict Prognosis in Colorectal Carcinoma.
    Xu F; Li S; Zhang J; Wang L; Wu X; Wang J; Huang Q; Lai M
    Clin Colorectal Cancer; 2018 Sep; 17(3):e579-e592. PubMed ID: 29921496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-derived scaffolds influence secretion profiles in cancer cells mirroring clinical features and breast cancer subtypes.
    Persson E; Gregersson P; Gustafsson A; Fitzpatrick P; Rhost S; Ståhlberg A; Landberg G
    Cell Commun Signal; 2021 Jun; 19(1):66. PubMed ID: 34090457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-derived scaffolds uncover breast cancer promoting properties of the microenvironment.
    Landberg G; Fitzpatrick P; Isakson P; Jonasson E; Karlsson J; Larsson E; Svanström A; Rafnsdottir S; Persson E; Gustafsson A; Andersson D; Rosendahl J; Petronis S; Ranji P; Gregersson P; Magnusson Y; Håkansson J; Ståhlberg A
    Biomaterials; 2020 Mar; 235():119705. PubMed ID: 31978840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of dieckol on hypoxia-induced epithelial-mesenchymal transition of HT29 human colorectal cancer cells.
    Jeong SH; Jeon YJ; Park SJ
    Mol Med Rep; 2016 Dec; 14(6):5148-5154. PubMed ID: 27779676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of cancer stem cell markers in human colorectal carcinoma cells in a microenvironment dependent manner.
    Stankevicius V; Kunigenas L; Stankunas E; Kuodyte K; Strainiene E; Cicenas J; Samalavicius NE; Suziedelis K
    Biochem Biophys Res Commun; 2017 Mar; 484(4):726-733. PubMed ID: 28174005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimized alginate-based 3D printed scaffolds as a model of patient derived breast cancer microenvironments in drug discovery.
    Svanström A; Rosendahl J; Salerno S; Leiva MC; Gregersson P; Berglin M; Bogestål Y; Lausmaa J; Oko A; Chinga-Carrasco G; Petronis S; Standoft S; Ståhlberg A; Håkansson J; Landberg G
    Biomed Mater; 2021 Jun; 16(4):. PubMed ID: 34030145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone inhibits hypoxia-induced epithelial-mesenchymal transition in colon cancer.
    Kim JH; Hwang YJ; Han SH; Lee YE; Kim S; Kim YJ; Cho JH; Kwon KA; Kim JH; Kim SH
    World J Gastroenterol; 2015 Sep; 21(34):9887-99. PubMed ID: 26379394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STC2 promotes the epithelial-mesenchymal transition of colorectal cancer cells through AKT-ERK signaling pathways.
    Chen B; Zeng X; He Y; Wang X; Liang Z; Liu J; Zhang P; Zhu H; Xu N; Liang S
    Oncotarget; 2016 Nov; 7(44):71400-71416. PubMed ID: 27662663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of hERG1 ion channels in epithelial-mesenchymal transition and the capacity of riluzole to reduce cisplatin resistance in colorectal cancer cells.
    Fortunato A
    Cell Oncol (Dordr); 2017 Aug; 40(4):367-378. PubMed ID: 28593575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human breast cancer decellularized scaffolds promote epithelial-to-mesenchymal transitions and stemness of breast cancer cells in vitro.
    Liu G; Wang B; Li S; Jin Q; Dai Y
    J Cell Physiol; 2019 Jun; 234(6):9447-9456. PubMed ID: 30478896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
    Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
    Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of WNT7b autocrine eases metastasis of colorectal cancer via epithelial to mesenchymal transition and predicts poor prognosis.
    Jiang S; Li Q; Liu Y; Zhang H; Wang Q; Chen Y; Shi X; Li J; Zhang H; Zhang Y; Xia D; Wu M; Lin J; Zhang C; Pang S; Jiang J; Wen Y; Zhang P
    BMC Cancer; 2021 Feb; 21(1):180. PubMed ID: 33607955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombomodulin Influences the Survival of Patients with Non-Metastatic Colorectal Cancer through Epithelial-To-Mesenchymal Transition (EMT).
    Chang YJ; Cheng YW; Lin RK; Huang CC; Chen WT; Ke TW; Wei PL
    PLoS One; 2016; 11(8):e0160550. PubMed ID: 27512995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated soluble E-cadherin during the epithelial-mesenchymal transition process and as a diagnostic marker in colorectal cancer.
    Zhu S; Zhao G; Zhao X; Zhan X; Cai M; Geng C; Pu Q; Zhao Q; Fu Q; Huang C; Wang Q
    Gene; 2020 Sep; 754():144899. PubMed ID: 32544494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 33/ST2 Axis Components Are Associated to Desmoplasia, a Metastasis-Related Factor in Colorectal Cancer.
    Landskron G; De la Fuente López M; Dubois-Camacho K; Díaz-Jiménez D; Orellana-Serradell O; Romero D; Sepúlveda SA; Salazar C; Parada-Venegas D; Quera R; Simian D; González MJ; López-Köstner F; Kronberg U; Abedrapo M; Gallegos I; Contreras HR; Peña C; Díaz-Araya G; Roa JC; Hermoso MA
    Front Immunol; 2019; 10():1394. PubMed ID: 31281317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.